CLLS
Cellectis SA
NASDAQ: CLLS · HEALTHCARE · BIOTECHNOLOGY
$3.90
+4.56% today
Updated 2026-04-30
Market cap
$391.30M
P/E ratio
—
P/S ratio
4.92x
EPS (TTM)
$-0.67
Dividend yield
—
52W range
$1 – $5
Volume
0.0M
Cellectis SA (CLLS) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-5.62M | $1.78M | $-7.05M | $-21.10M | $-13.19M | $-26.11M | $-25.63M | $50.74M | $3.54M | $-31.09M | $-52.33M | $-68.14M | $-69.14M | $-80.26M | $-104.56M | $-87.44M | $-24.75M | $22.10M | $-40.14M |
| Capital expenditures | $147258.00 | $790711.00 | $713507.00 | $6.66M | $4.25M | $5.49M | $1.91M | $430468.00 | $4.25M | $13.34M | $2.66M | $4.89M | $12.96M | $44.42M | $18.56M | $2.44M | $1.07M | $2.58M | $2.37M |
| Depreciation | $852931.00 | $400924.00 | $368215.00 | $1.58M | — | $2.42M | $45.93M | $1.67M | $1.91M | $2.10M | $3.37M | $2.38M | $6.88M | $7.83M | $14.16M | $18.43M | $18.52M | $19.84M | — |
| Stock-based comp | $351378.00 | $281203.00 | — | $578534.00 | — | $254466.00 | $634855.00 | $666374.00 | $32.91M | $55.71M | $50.42M | $37.22M | $26.88M | $10.03M | $11.49M | $6.04M | $5.23M | $3.17M | $6.11M |
| Free cash flow | $-5.77M | $988390.00 | $-7.76M | $-27.76M | $-17.44M | $-31.60M | $-27.54M | $50.31M | $-715020.00 | $-44.42M | $-54.98M | $-73.02M | $-82.10M | $-124.68M | $-123.12M | $-89.89M | $-25.82M | $19.52M | $-42.50M |
| Investing cash flow | $316386.00 | $-1.12M | $316637.00 | $-5.69M | $-29.41M | $-6.10M | $-2.08M | $-1.65M | $-7.61M | $-50.50M | $1.78M | $35.62M | $-35.87M | $-54.34M | $7.28M | $-2.76M | $-15.51M | $-102.63M | — |
| Financing cash flow | $34.79M | $4.05M | $30.91M | $-1.18M | $66.39M | $4.93M | $7.50M | $70.41M | $217.35M | $460645.00 | $41.27M | $236.49M | $-3.86M | $27.32M | $47.52M | $1.15M | $82.86M | $89.80M | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — | — | — | $0.00 | $0.00 | $569000.00 | $0.00 | $0.00 | $0.00 |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |